Generation Bio Co.
GBIO
$0.3878
$0.01353.61%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -21.38M | -15.31M | -20.43M | -74.54M | -35.19M |
Total Depreciation and Amortization | 1.18M | 1.18M | 1.26M | 1.31M | 1.33M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 5.30M | 2.50M | 3.21M | 58.60M | 3.45M |
Change in Net Operating Assets | -875.00K | -7.92M | -5.58M | -17.06M | 5.43M |
Cash from Operations | -15.78M | -19.55M | -21.54M | -31.70M | -24.98M |
Capital Expenditure | -378.00K | -91.00K | -14.00K | -1.92M | -4.58M |
Sale of Property, Plant, and Equipment | 47.00K | 45.00K | 104.00K | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 70.62M | 12.75M | 12.00M | 1.37M | 2.67M |
Cash from Investing | 70.28M | 12.71M | 12.09M | -553.00K | -1.91M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 158.00K | 13.00K | 265.00K | -- | 179.00K |
Repurchase of Common Stock | -14.00K | -16.00K | -31.00K | -125.00K | -117.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | 15.00K |
Cash from Financing | 144.00K | -3.00K | 234.00K | -125.00K | 77.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 54.64M | -6.84M | -9.21M | -32.38M | -26.82M |